Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
59,255,636
-
Shares change
-
+15,668,509
-
Total reported value, excl. options
-
$2,326,748,242
-
Value change
-
+$609,713,327
-
Put/Call ratio
-
35.98%
-
Number of buys
-
121
-
Number of sells
-
-45
-
Price
-
$39.27
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q2 2024
206 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q2 2024.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59,255,636 shares
of 172,779,139 outstanding shares and own 34.3% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (7,547,920 shares), FMR LLC (5,744,809 shares), JANUS HENDERSON GROUP PLC (3,354,269 shares), Capital Research Global Investors (3,131,310 shares), Driehaus Capital Management LLC (2,577,136 shares), BVF INC/IL (2,487,762 shares), FEDERATED HERMES, INC. (2,407,206 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,313,521 shares), RA CAPITAL MANAGEMENT, L.P. (1,896,772 shares), and Capital International Investors (1,498,644 shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.